Intelligence · Clinical Pipeline
Neurology & CNS · Phase II
Neurology & CNS programs at Phase II — ClinicalTrials.gov pipeline intelligence.
- Programs
- 230
Quick answer
Neurology & CNS Phase II programs: NovaPharmaNews indexes 230 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 13 programs
- United Therapeutics Europe 12 programs
- Chinese Academy of 11 programs
- Teva Pharma 11 programs
- Jazz Pharmaceuticals Ireland 10 programs
- Acadia Pharmaceuticals 9 programs
- HOFFMANN-LA ROCHE 9 programs
- George Institute for 8 programs
- SUPERNUS PHARMACEUTICALS 8 programs
- Cognition Therapeutics 7 programs
- Takeda 7 programs
- Anaxis Pharma 6 programs
-
MINOCIN 100 mg capsule rigide
Zafatek
Depression
1 trial -
MK-1167
Merck KGaA, Darmstadt, Germany
Alzheimer Disease
1 trial -
MK-2214
Merck KGaA, Darmstadt, Germany
Early Alzheimer's Disease
1 trial -
MK-2214, Florquinitau F18, Placebo to MK-2214
Merck Sharp and Dohme
Alzheimer’s Disease
1 trial -
ML-007C-MA
MapLight Therapeutics
Schizophrenia
1 trial -
ML-007C-MA
MapLight Therapeutics
Psychosis Associated With Alzheimer's Disease
2 trials -
MLC901
Hospital Authority, Hong Kong
Alzheimer Disease
1 trial -
Matched Placebo for test product Frexalimab, Frexalimab
Sanofi-aventis Healthcare Pty Ltd
Multiple Sclerosis
1 trial -
Matched placebo for product, GADOBUTROL , SAR443820
Sanofi-aventis Healthcare Pty Ltd
Multiple sclerosis
1 trial -
Matching Placebo tablets without active substance, BIIB122
Biogen
Parkinson's Disease
1 trial -
Mebufotenin, Mebufotenin, Inhalation vapour, liquid, Mebufotenin
Elan Pharma International
Treatment-resistant depression (TRD)
1 trial -
Melperone HCl
Lundbeck Australia Pty Ltd
Parkinson's Disease
1 trial -
Mifepristone
CORCEPT THERAPEUTICS INC
Alzheimer's Disease
1 trial -
Mivelsiran, Placebo
Alnylam Netherlands B.V.
Cerebral Amyloid Angiopathy (CAA) is a neurological condition in which amyloid proteins build up in the walls of blood vessels in the brain, causing problems such as bleeding into the brain
1 trial -
Morphine
Hospital Authority, Hong Kong
Respiratory Depression
1 trial -
N-acetyl cysteine
United Therapeutics Europe Ltd
Multiple Sclerosis
1 trial -
N-acetylcysteine capsule
United Therapeutics Europe Ltd
Parkinson Disease
1 trial -
NBI-1117570
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
NBI-1117570, NBI-1117570, Placebo for nbi-1117570
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
NBI-5788
NEUROCRINE BIOSCIENCES INC
Multiple Sclerosis
1 trial -
NMDAE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prodromal Schizophrenia
1 trial -
NMDAE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
2 trials -
NMDAE plus AIFA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Schizophrenia
1 trial -
NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Treatment Resistant Depression
1 trial -
NeuroEPO
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Parkinson Disease
1 trial -
NurOwn (MSC-NTF cells)
BRAINSTORM CELL THERAPEUTICS INC.
Multiple Sclerosis, Chronic Progressive
1 trial -
OPC-34712
Otsuka Beijing Research Institute
Schizophrenia
1 trial -
ORY-2001 Low dose
BRIGHT MINDS BIOSCIENCES INC.
Mild to Moderate Alzheimer's Disease
1 trial -
Obexelimab
Zenas BioPharma
Relapsing Multiple Sclerosis
1 trial -
Ocrevus 300 mg concentrate for solution for infusion, CYTARABINE, CARMUSTINE, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE, Tysabri 300 mg concentrate for solution for infusion, CARMUSTINE, ETOPOSIDE, CARMUSTINE, UBLITUXIMAB, MELPHALAN FLUFENAMIDE, FILGRASTIM, FILGRASTIM, CYTARABINE, CYTARABINE, CYCLOPHOSPHAMIDE, RABBIT ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, Kesimpta 20 mg solution for injection in pre-filled pen, ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS, CYTARABINE, LEMTRADA 12 mg concentrate for solution f
Fondazione Telethon ETS
Relapsing Remitting Multiple Sclerosis
1 trial -
Ocrevus, Ocrevus 920 mg solution for injection, Ocrevus, Ocrelizumab
Hoffmann-La Roche
Multiple Sclerosis (MS)
1 trial -
PCN-101
Chongqing Precision Biotech Co., Ltd
Treatment Resistant Depression
1 trial -
PEG-liposomal prednisolone sodium phosphate
Lakefront Biotherapeutics NV
Acute Exacerbation of Remitting Relapsing Multiple Sclerosis
1 trial -
PIPE-307 Dose A
Contineum Therapeutics
Relapsing Remitting Multiple Sclerosis
1 trial -
PRENUMBRA
Clinuvel Europe Limited
Parkinson's Disease
1 trial -
PROLEUKIN 18 millions U.I., poudre pour solution injectable, CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule
Pari Pharma GmbH
Alzheimer Disease
1 trial -
Pepinemab
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Perindopril
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer's Disease
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Treatment of Depression in Adults With Parkinson's Disease (PD)
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Parkinson's Disease
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Agitation and Aggression in Alzheimer's Disease
1 trial -
Pimavanserin 34 mg
Acadia Pharmaceuticals B.V.
Agitation and Aggression in Alzheimer's Disease
1 trial -
Pimavanserin 34 milligrams (MG) [Nuplazid]
Acadia Pharmaceuticals B.V.
Schizophrenia
1 trial -
Pimavanserin tartrate
Acadia Pharmaceuticals B.V.
Alzheimer's Disease Psychosis
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Bipolar Depression
1 trial -
Placebo
MapLight Therapeutics
Schizophrenia
1 trial -
Placebo
Teva Pharma GmbH
Primary Progressive Multiple Sclerosis
1 trial
Frequently asked questions
How many neurology & cns Phase II programs exist?
230 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs